TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population

Thyroid hormones may be a risk factor for the development of non-alcoholic fatty liver disease (NAFLD) and its progression to liver fibrosis. The aim of this study is to investigate the relationship between thyroid stimulating hormone (TSH) levels, NAFLD, and liver fibrosis in the general population. A descriptive cross-sectional study was performed in subjects aged 18-75 years randomly selected from primary care centers between 2012 and 2016. Each subject underwent clinical evaluation, physical examination, blood tests and transient elastography. Descriptive and multivariate logistic regression analyses were used to identify factors associated with NAFLD and fibrosis. We included 2452 subjects (54 +/- 12 years; 61% female). Subjects with TSH >= 2.5 mu IU/mL were significantly associated with obesity, atherogenic dyslipidemia, metabolic syndrome (MetS), hypertransaminasemia and altered cholesterol and triglycerides. The prevalence of NAFLD and liver fibrosis was significantly higher in subjects with TSH >= 2.5 (mu IU/mL). We found a 1.5 times increased risk of NAFLD, 1.8 and 2.3 times increased risk of liver fibrosis for cut-off points of >= 8.0 kPa and >= 9.2 kPa, respectively, in subjects with TSH >= 2.5 mu IU/mL compared with TSH < 2.5 mu IU/mL (control group), independent of the presence of MetS. These findings remained significant when stratifying TSH, with values >= 10 mu IU/mL.